Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2020 1
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.
Ntinginya NE, Bakuli A, Mapamba D, Sabiiti W, Kibiki G, Minja LT, Kuchaka D, Reither K, Phillips PPJ, Boeree MJ, Gillespie SH, Hoelscher M, Heinrich N; Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) Consortium. Ntinginya NE, et al. Among authors: kuchaka d. Clin Infect Dis. 2023 Feb 8;76(3):e990-e994. doi: 10.1093/cid/ciac445. Clin Infect Dis. 2023. PMID: 35717643 Free PMC article.
Nanopore sequencing technology for clinical diagnosis of infectious diseases where laboratory capacity is meager: A case report.
Kumburu HH, Shayo M, van Zwetslaar M, Njau J, Kuchaka DJ, Ignas IP, Wadugu B, Kasworm R, Masaki LJ, Hallgren MB, Clausen PTLC, Mmbaga BT, Aarestrup FM, Sonda TB. Kumburu HH, et al. Among authors: kuchaka dj. Heliyon. 2023 Jun 28;9(7):e17439. doi: 10.1016/j.heliyon.2023.e17439. eCollection 2023 Jul. Heliyon. 2023. PMID: 37539288 Free PMC article.
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.
Sabiiti W, Azam K, Farmer ECW, Kuchaka D, Mtafya B, Bowness R, Oravcova K, Honeyborne I, Evangelopoulos D, McHugh TD, Khosa C, Rachow A, Heinrich N, Kampira E, Davies G, Bhatt N, Ntinginya EN, Viegas S, Jani I, Kamdolozi M, Mdolo A, Khonga M, Boeree MJ, Phillips PPJ, Sloan D, Hoelscher M, Kibiki G, Gillespie SH. Sabiiti W, et al. Among authors: kuchaka d. Thorax. 2020 Jul;75(7):606-608. doi: 10.1136/thoraxjnl-2019-214238. Epub 2020 Apr 30. Thorax. 2020. PMID: 32354738 Free PMC article.
Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.
Ruhwald M, de Thurah L, Kuchaka D, Zaher MR, Salman AM, Abdel-Ghaffar AR, Shoukry FA, Michelsen SW, Soborg B, Blauenfeldt T, Mpagama S, Hoff ST, Agger EM, Rosenkrands I, Aagard C, Kibiki G, El-Sheikh N, Andersen P. Ruhwald M, et al. Among authors: kuchaka d. Sci Rep. 2017 Apr 7;7:45969. doi: 10.1038/srep45969. Sci Rep. 2017. PMID: 28387329 Free PMC article.
Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting.
Ntinginya NE, Kuchaka D, Orina F, Mwebaza I, Liyoyo A, Miheso B, Aturinde A, Njeleka F, Kiula K, Msoka EF, Meme H, Sanga E, Mwanyonga S, Olomi W, Minja L, Joloba M, Mmbaga BT, Amukoye E, Gillespie SH, Sabiiti W. Ntinginya NE, et al. Among authors: kuchaka d. BMJ Glob Health. 2021 Aug;6(8):e005357. doi: 10.1136/bmjgh-2021-005357. BMJ Glob Health. 2021. PMID: 34429298 Free PMC article.
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
Sabiiti W, Mtafya B, Kuchaka D, Azam K, Viegas S, Mdolo A, Farmer EC, Khonga M, Evangelopoulos D, Honeyborne I, Rachow A, Heinrich N, Ntinginya NE, Bhatt N, Davies GR, Jani IV, McHugh TD, Kibiki G, Hoelscher M, Gillespie SH; PANBIOME (Pan-African Biomarker Expansion Programme) consortium. Sabiiti W, et al. Among authors: kuchaka d. Int J Tuberc Lung Dis. 2016 Aug;20(8):1004-9. doi: 10.5588/ijtld.15.0951. Int J Tuberc Lung Dis. 2016. PMID: 27393531
Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda.
Musisi E, Wamutu S, Ssengooba W, Kasiinga S, Sessolo A, Sanyu I, Kaswabuli S, Zawedde J, Byanyima P, Kia P, Muwambi W, Toskin DT, Kigozi E, Walbaum N, Dombay E, Legrady MB, Ssemambo KD, Joloba M, Kuchaka D, Worodria W, Huang L, Gillespie SH, Sabiiti W. Musisi E, et al. Among authors: kuchaka d. Lancet Microbe. 2024 Apr;5(4):e345-e354. doi: 10.1016/S2666-5247(23)00367-1. Epub 2024 Mar 5. Lancet Microbe. 2024. PMID: 38458206 Free article.